Yahoo Finance

Viatris Announces Launch of Breyna(TM) (Budesonide and Formoterol Fumarate Dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People With ...

PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ ...
Monthly Prescribing Reference

First Generic Version of Symbicort Gets FDA Approval

Asthma diagram, lungs Breyna is a metered-dose inhaler containing budesonide, a corticosteroid, and formoterol, a long-acting bronchodilator. The Food and Drug Administration (FDA) has approved ...
Finanznachrichten

Viatris Announces Launch of Breyna Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort for People With Asthma and Chronic Obstructive Pulmonary Disease, in ...

PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna (budesonide ...
KELOLAND News

Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with ...

PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide ...